A-119
Aripiprazole solution
1.0 mg/mL (50:50 Methanol/Water with 1% 1N HCl), ampule of 1 mL, certified reference material, Cerilliant®
Manufacturer: Supelco
CAS Number: 129722-12-9
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 1 ML | A-119-1-ML | In Stock | ₹ 19,391.40 |
A-119 - 1 ML
In Stock
Quantity
1
Base Price: ₹ 19,391.40
GST (18%): ₹ 3,490.452
Total Price: ₹ 22,881.852
grade
certified reference material
Quality Level
300
form
liquid
feature
(Snap-N-Spike®)
packaging
ampule of 1 mL
manufacturer/tradename
Cerilliant®
concentration
1.0 mg/mL (50:50 Methanol/Water with 1% 1N HCl)
technique(s)
gas chromatography (GC): suitableliquid chromatography (LC): suitable
application(s)
clinical testing
format
single component solution
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | Tocris Bioscience™ Aripiprazole | -- | ₹ 13,638.26 | |
| | Aripiprazole Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™ | -- | ₹ 29,774.88 | |
| | Medchemexpress LLC HY-14546 1g , Aripiprazole CAS:129722-12-9 Purity:98% | -- | ₹ 15,991.16 | |
| | Aripiprazole | -- | ₹ 40,756.13 | |
| | Aripiprazole | -- | ₹ 14,267.35 | |
| | 2(1H)-Quinolinone, 7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro- | -- | ₹ 427.80 - ₹ 16,427.52 | |
| | 129722-12-9 | 7-{4-[4-(2,3-Dichloro-phenyl)-piperazin-1-yl]-butoxy}-3,4-dihydro-1H-quinol in-2-one | -- | ₹ 1,454.52 - ₹ 28,234.80 |
Related Products
Description
- General description: A Certified Solution Standard for use in LC or GC applications including forensic drug analysis or calibrator preparation. Aripiprazole is marketed as the atypical antipsychotic Abilify® for the treatment of schizophrenia, bipolar disorder and clinical depression.
- Application: Psychoactive Drug Detection: The development of a fast UPLC-MS/MS method for detecting psychoactive drugs and metabolites in blood, which utilized Interference Mix 6, underscores its critical application in forensic toxicology and clinical pharmacology, aiding in post-mortem analysis (Barone et al., 2023).
- Legal Information: Abilify is a registered trademark of Otsuka Pharmaceutical Co.
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
P210 - P233 - P280 - P301 + P310 - P303 + P361 + P353 - P304 + P340 + P311
Hazard Classifications
Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
Target Organs
Eyes,Central nervous system
WGK
WGK 2
Flash Point(F)
51.8 °F
Flash Point(C)
11 °C